Global Cancer Biomarkers Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431855
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • MORE
Cancer Biomarkers Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 - 2025, the cancer biomarkers market was valued at USD 10,514.0 Mn in 2016, and is expected to reach USD 30,284.5 Mn by 2025, expanding at a CAGR of 11.5% from 2017 to 2025.

Market Insights

According to Provista Diagnostics, there are six types of biomarkers in cancer research such as risk assessment, screening/detection, diagnosis, prognosis, prediction and monitoring. In case of risk assessment biomarkers identify factors to access disease susceptibility, screening biomarkers indicate the early presence of disease, and predicting biomarkers predict efficacy or response to several treatments. In recent years, remarkable advances have taken place in understanding the molecular mechanism of cancer progression which has transformed the way people can observe the process of malignant transformation. Moreover, market experts also feel that this knowledge should be translate to provide better treatments for cancer patients. This development has successfully enticed the interest towards the development of targeted therapies for cancer and personalized medicine.

The overall market segmentation of cancer biomarkers market comprises by type, cancer type, profiling technologies type, and application type. In year 2016, proteomic biomarkers dominated the market by type due to exceptional market potential of protein biomarkers in diagnostics, prognostics, cancer detection and other clinical & therapeutic applications. In addition, increasing focus of pharmaceutical & biotechnology companies in research and development of protein biomarkers is expected to fuel the overall market growth.

In year 2016, breast cancer dominated the cancer biomarkers market by cancer type due to rising prevalence of disease, high awareness associated with early diagnosis, increasing public awareness with assistance of government and non-government organizations, and rising research and development activities in the field of breast cancer diagnosis. During the forecast period 2017 - 2025, lung cancer was observed as the fastest growing segment due to key driving factors such as rising prevalence of lung cancer due to increase in air pollution and frequent smoking observed in young generation.

In case of profiling technologies omics technologies accounted for the largest share of the cancer biomarkers market and also the fastest growing segment due to key driving factors such as increased adoption of advanced high throughput technologies in biomarker discovery and development and rising application of omics-based tests for cancer diagnosis and drug development process. In addition, incessant developments in high-throughput omics technologies are also backing the growth of this market, by rising the space of prospective biomarkers in cancer research.

In year 2016, applications segment was dominated by diagnostics due to key driving factors such as increasing awareness amongst patients about the importance of early diagnosis of cancer and diagnostic biomarkers enable doctors to decide effective treatment alternatives.

North America dominated the cancer biomarkers market in year 2016 due to key driving factors such as increasing adoption of innovative technology, headquarters of key pharmaceutical companies are based in North America, established R&D infrastructure pertaining to the development of novel diagnostic products, and increased demand for specific & early diagnostics. Asia Pacific region was observed as the fastest growing segment due to increasing prevalence of cancer, beneficial environment for clinical trials, and increasing government support for drug development programs is anticipated to witness lucrative CAGR.

Market Competition Assessment

The cancer biomarkers market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Abbott Laboratories, Affymetrix, Inc., DiagnoCure Inc. Qiagen N.V., Illumina, Inc., Roche Diagnostics Ltd., Quest Diagnostics Inc., Agilent Technologies Inc., Merck & Co. Inc., Hologic, Inc., and Becton Dickinson and Company among others.

Key Market Movements:
  • Rising prevalence of cancer in developed as well as developing countries
  • Increasing application of biomarkers in the drug discovery and development process
  • Supportive government policies and awareness activities carried out by non-government organization
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Hologic, Inc.
  • Illumina, Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase II-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Cancer Biomarkers Market Portraiture
2.1.1. Global Cancer Biomarkers Market, by Type, 2016
2.1.2. Global Cancer Biomarkers Market, by Type of Cancer, 2016
2.1.3. Global Cancer Biomarkers Market, by Profiling Technologies, 2016
2.1.4. Global Cancer Biomarkers Market, by Application, 2016
2.1.5. Global Cancer Biomarkers Market, by Geography, 2016

Chapter 3. Cancer Biomarkers Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Cancer: Epidemiology & Diagnosis Rate
3.3. Cancer Biomarkers: Price Analysis
3.4. Cancer Biomarkers: Future Trends
3.5. Drivers
3.6. Challenges
3.7. Opportunities
3.8. Attractive Investment Proposition, by Geography, 2016
3.9. Major Agreements, Partnerships and Collaborations
3.10. Competitive Landscape
3.10.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Cancer Biomarkers Market, by Type
4.2. Genetic Biomarkers
4.3. Epigenetic Biomarkers
4.4. Metabolic Biomarkers
4.5. Proteomic Biomarkers
4.6. Others

Chapter 5. Global Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Cancer Biomarkers Market, by Type of Cancer
5.2. Breast Cancer
5.3. Lung Cancer
5.4. Colorectal Cancer
5.5. Prostate Cancer
5.6. Cervical Cancer
5.7. Others

Chapter 6. Global Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Cancer Biomarkers Market, by Type of Profiling Technologies
6.2. Immunoassays
6.3. Omics Technologies
6.4. Cytogenetics
6.5. Imaging Technologies
6.6. Bioinformatics

Chapter 7. Global Cancer Biomarkers Market, by Type of Application, 2015 - 2025 (US$ Mn)
7.1. Overview
7.1.1. Attractive Investment Proposition: Global Cancer Biomarkers Market, by Type of Application
7.2. Diagnostics
7.3. Drug Discovery & Development
7.4. Prognostics
7.5. Risk Assessment
7.6. Others

Chapter 8. Global Cancer Biomarkers Market, by Geography, 2015 - 2025 (US$ Mn)
8.1. Overview
8.2. North America Cancer Biomarkers Market Analysis, 2015 - 2025
8.2.1. North America Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
8.2.2. North America Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
8.2.3. North America Cancer Biomarkers Market, by Profiling Technologies, 2015 - 2025 (US$ Mn)
8.2.4. North America Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
8.2.5. North America Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
8.2.5.1. U.S.
8.2.5.2. Canada
8.3. Europe Cancer Biomarkers Market Analysis, 2015 - 2025
8.3.1. Europe Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
8.3.2. Europe Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
8.3.3. Europe Cancer Biomarkers Market, by Profiling Technologies, 2015 - 2025 (US$ Mn)
8.3.4. Europe Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
8.3.5. Europe Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
8.3.5.1. U.K.
8.3.5.2. Germany
8.3.5.3. France
8.3.5.4. Spain
8.3.5.5. Italy
8.3.5.6. Rest of Europe
8.4. Asia Pacific Cancer Biomarkers Market Analysis, 2015 - 2025
8.4.1. Asia Pacific Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
8.4.2. Asia Pacific Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
8.4.3. Asia Pacific Cancer Biomarkers Market, by Profiling Technologies, 2015 - 2025 (US$ Mn)
8.4.4. Asia Pacific Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
8.4.5. Asia Pacific Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
8.4.5.1. Japan
8.4.5.2. China
8.4.5.3. India
8.4.5.4. Rest of APAC
8.5. Latin America Cancer Biomarkers Market Analysis, 2015 - 2025
8.5.1. Latin America Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
8.5.2. Latin America Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
8.5.3. Latin America Cancer Biomarkers Market, by Profiling Technologies, 2015 - 2025 (US$ Mn)
8.5.4. Latin America Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
8.5.5. Latin America Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
8.5.5.1. Brazil
8.5.5.2. Mexico
8.5.5.3. Rest of Latin America
8.6. Middle East & Africa (MEA) Cancer Biomarkers Market Analysis, 2015 - 2025
8.6.1. MEA Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
8.6.2. MEA Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
8.6.3. MEA Cancer Biomarkers Market, by Profiling Technologies, 2015 - 2025 (US$ Mn)
8.6.4. MEA Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
8.6.5. MEA Cancer Biomarkers Market, by Region, 2015 - 2025 (US$ Mn)
8.6.5.1. UAE
8.6.5.2. Saudi Arabia
8.6.5.3. South Africa
8.6.5.4. Rest of MEA

Chapter 9. Company Profiles
9.1. Abbott Laboratories
9.1.1. Business Description
9.1.2. Financial Information (Subject to data availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. Affymetrix, Inc.
9.3. Illumina, Inc.
9.4. Qiagen N.V.
9.5. Roche Diagnostics Ltd.
9.6. Agilent Technologies, Inc.
9.7. Quest Diagnostics Inc.
9.8. Merck & Co. Inc.
9.9. Hologic, Inc.
9.10. Becton, Dickinson and Company
9.11. Sino Biological Inc.

List of Figures
Fig. 1 Cancer Biomarkers: Market Segmentation
Fig. 2 Global Cancer Biomarkers Market Share, by Type, 2016 (Value %)
Fig. 3 Global Cancer Biomarkers Market, by Type of Cancer, 2016 (US$ Mn)
Fig. 4 Global Cancer Biomarkers Market Share, by Type of Profiling Technologies, 2016 (Value %)
Fig. 5 Global Cancer Biomarkers Market, by Type of Application, 2016 (US$ Mn)
Fig. 6 Global Cancer Biomarkers Market, by Geography, 2016 (Value %)
Fig. 7 Attractive Investment Proposition, by Geography, 2016
Fig. 8 Market Competition Landscape, by Key Players, 2016
Fig. 9 Global Genetic Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Epigenetic Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Metabolic Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Proteomic Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Other Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global Breast Cancer Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 15 Global Lung Cancer Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 16 Global Colorectal Cancer Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 17 Global Prostate Cancer Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 18 Global Cervical Cancer Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 19 Global Other Cancers Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 20 Global Immunoassays Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 21 Global Omics Technologies Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 22 Global Cytogenetics Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 23 Global Imaging Technologies Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 24 Global Bioinformatics Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 25 Global Diagnostics Application Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 26 Global Drug Discovery & Development Application Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 27 Global Prognostics Application Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 28 Global Risk Assessment Application Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 29 Global Other Applications Market in Cancer Biomarkers, 2015 - 2025 (US$ Mn)
Fig. 30 U.S. Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 31 Canada Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 32 U.K. Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 33 Germany Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 34 France Cancer Biomarkers Market, 2015-2025 (US$ Mn)
Fig. 35 Spain Cancer Biomarkers Market, 2015-2025 (US$ Mn)
Fig. 36 Italy Cancer Biomarkers Market, 2015-2025 (US$ Mn)
Fig. 37 Rest of Europe Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 38 Japan Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 39 China Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 40 India Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 41 Rest of Asia Pacific Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 42 Brazil Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 43 Mexico Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 44 Rest of Latin America Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 45 UAE Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 46 Saudi Arabia Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 47 South Africa Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)
Fig. 48 Rest of Middle East and Africa Cancer Biomarkers Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 2 Global Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 3 Global Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 4 Global Cancer Biomarkers Market, by Type of Application, 2015 - 2025 (US$ Mn)
Table 5 Global Cancer Biomarkers Market, by Type of Geography, 2015 - 2025 (US$ Mn)
Table 6 North America Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 7 North America Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 8 North America Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 9 North America Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
Table 10 North America Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
Table 11 Europe Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 12 Europe Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 13 Europe Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 14 Europe Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
Table 15 Europe Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
Table 16 Asia Pacific Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 17 Asia Pacific Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 18 Asia Pacific Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 19 Asia Pacific Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
Table 20 Asia Pacific Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
Table 21 Latin America Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 22 Latin America Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 23 Latin America Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 24 Latin America Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
Table 25 Latin America Cancer Biomarkers Market, by Country, 2015 - 2025 (US$ Mn)
Table 26 Middle East and Africa Cancer Biomarkers Market, by Type, 2015 - 2025 (US$ Mn)
Table 27 Middle East and Africa Cancer Biomarkers Market, by Type of Cancer, 2015 - 2025 (US$ Mn)
Table 28 Middle East and Africa Cancer Biomarkers Market, by Type of Profiling Technologies, 2015 - 2025 (US$ Mn)
Table 29 Middle East and Africa Cancer Biomarkers Market, by Application, 2015 - 2025 (US$ Mn)
Table 30 Middle East and Africa Cancer Biomarkers Market, by Region, 2015 - 2025 (US$ Mn)
Table 31 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 32 Affymetrix, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 33 DiagnoCure Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 34 Qiagen N.V.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 35 Illumina, Inc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 36 Roche Diagnostics Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 37 Quest Diagnostics Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 38 Agilent Technologies Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 39 Merck & Co. Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 40 Hologic, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 41 Becton Dickinson and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 42 Sino Biological Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Illumina, Inc.
  • Qiagen N.V.
  • Roche Diagnostics Ltd.
  • Agilent Technologies, Inc.
  • Quest Diagnostics Inc.
  • Merck & Co. Inc.
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Sino Biological I
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll